Literature DB >> 20424568

Membrane designs and composition for hemodialysis, hemofiltration and hemodialfiltration: past, present and future.

A Davenport1.   

Abstract

Today hemodialysis is a routine outpatient treatment, not only carried out in hospitals, but more commonly in free standing units without on site medical supervision. One of the key advances that have underpinned this expansion of hemodialysis provision has been the technological advances in dialyzer membrane technology. Dialyzer membranes have undergone a sea change from collodion tubes to cellulose sheets to the modern day capillary fiber dialyzer. Improvements have not only been limited to reliability of manufacture, but also reduction in bio-incompatibility, and improved small solute clearances. However, the holy Grail remains the development of a dialyzer capable of removing middle sized azotemic retention solutes, and protein bound or lipophilic solutes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424568

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  8 in total

Review 1.  A molecular description of cellulose biosynthesis.

Authors:  Joshua T McNamara; Jacob L W Morgan; Jochen Zimmer
Journal:  Annu Rev Biochem       Date:  2015       Impact factor: 23.643

Review 2.  What are the anticoagulation options for intermittent hemodialysis?

Authors:  Andrew Davenport
Journal:  Nat Rev Nephrol       Date:  2011-07-05       Impact factor: 28.314

Review 3.  Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.

Authors:  Robert A DeAngelis; Edimara S Reis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

Review 4.  Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.

Authors:  Andrew Davenport
Journal:  Pediatr Nephrol       Date:  2012-02-29       Impact factor: 3.714

5.  Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients.

Authors:  Eugenia Papakrivopoulou; John Booth; Jennifer Pinney; Andrew Davenport
Journal:  Nephron Extra       Date:  2012-03-26

Review 6.  Treatment with echinocandins during continuous renal replacement therapy.

Authors:  Francisco González de Molina; Maria de Los Ángeles Martínez-Alberici; Ricard Ferrer
Journal:  Crit Care       Date:  2014-03-28       Impact factor: 9.097

Review 7.  Portable and wearable dialysis devices for the treatment of patients with end-stage kidney failure: Wishful thinking or just over the horizon?

Authors:  Andrew Davenport
Journal:  Pediatr Nephrol       Date:  2014-10-21       Impact factor: 3.714

8.  Hemodialysis Does Not Induce Detectable Activation of the Contact System of Coagulation.

Authors:  Karlien François; Christelle Orlando; Kristin Jochmans; Wilfried Cools; Vicky De Meyer; Christian Tielemans; Karl Martin Wissing
Journal:  Kidney Int Rep       Date:  2020-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.